Clinical trials
Follow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Masu Zhixiao Decoction Granules is a traditional Chinese medicine (TCM) herbal formulation developed by the Second Affiliated Hospital of Tianjin University of Traditional Chinese Medicine. It is formulated as oral granules and is primarily investigated for the treatment of acute exacerbations of bronchial asthma. In clinical trials, it has been evaluated as part of syndrome-differentiated TCM comprehensive therapy, often compared against or combined with conventional asthma pharmacotherapies (such as fluticasone propionate, salbutamol, and theophylline) and other TCM interventions like acupoint herbal application.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on Masu Zhixiao Decoction Granules.